Menu
GWAS Study

Genome-Wide Association Study of Beta-Blocker Survival Benefit in Black and White Patients with Heart Failure with Reduced Ejection Fraction.

Luzum JA

38002962 PubMed ID
GWAS Study Type
757 Participants
0 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

LJ
Luzum JA
Chapter II

Abstract

Summary of the research findings

469 African ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

757
Total Participants
GWAS
Study Type
Yes
Replicated
288 African ancestry individuals
Replication Participants
African unspecified
Ancestry
U.S., Canada, France
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.